中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝脏原发高级别神经内分泌癌1例报告

刘宇维 崔国振 刘相良 牛俊奇 赵恒军

引用本文:
Citation:

肝脏原发高级别神经内分泌癌1例报告

DOI: 10.3969/j.issn.1001-5256.2020.01.036
基金项目: 

国家重点基础研究发展计划(973计划)(2015CB554304); 

详细信息
  • 中图分类号: R735.7

A case of primary hepatic high-grade neuroendocrine carcinoma

Research funding: 

 

  • 摘要: <正>1病例资料患者男性,61岁,因"腹痛、乏力7 d"于2019年4月30日入本院,无恶心、呕吐,既往体健。入院查体:皮肤巩膜轻度黄染,右上腹部压痛明显,无其他阳性体征。入院血生化检查:TBil 31. 8μmol/L,DBil 9. 3μmol/L,IBil 22. 5μmol/L,ALT 135. 9 U/L,AST 163. 3 U/L,GGT 115. 1 U/L,余未见异常。肿瘤标志物:AFP3. 12 ng/ml,细胞角蛋白19片段20. 47 ng/ml,神经元特异性烯醇化酶(neuron-specific enolase,NSE) 176. 25 ng/ml。实验室指

     

  • [1] ZHAO J,YANG B,XU C,et al. Study on clinicopathologic grading system and prognosis of primary hepatic neuroendocrine neoplasms[J]. Chin J Pathol,2012,41(2):102-106.(in Chinese)赵婧,杨博,徐晨,等.肝脏原发性神经内分泌肿瘤临床病理分类及预后分析[J].中华病理学杂志,2012,41(2):102-106.
    [2] CAMARGOS,VIVEIROS MDE M,CORRA NETO IJ,et al.Primary hepatic carcinoid tumor:Case report and literature review[J]. Einstein,2014,12(4):505-508.
    [3] QUARTEY B. Primary hepatic neuroendocrine tumor:What do we know now?[J]. World J Oncol,2011,2(5):209-216.
    [4] EDMONDSON HA. Tumors of the liver and intrahepatic bile ducts:Atlas of tumor pathology,sect 7,fasc,25[M]. Washington DC:Armed Forces Institute of Pathology,1958:105-111.
    [5] MENG XF,PAN YW,WANG ZB,et al. Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years:A case report and literature review[J]. World J Gastroenterol,2018,24(24):2640-2646.
    [6] HU X,HUANG Z,ZHANG Y,et al. Primary hepatic neuroendocrine tumor:Report of one case[J]. Transl Gastroenterol Hepatol,2016,1:82.
    [7] GAO WH,XIANG XX. Primary hepatic neuroendocrine neoplasm:A report of 2 cases and literature review[J]. J Clin Hepatol,2017,33(6):1149-1151.(in Chinese)高伟华,向晓星.原发性肝脏神经内分泌肿2例报告并文献复习[J].临床肝胆病杂志,2017,33(6):1149-1151.
    [8] PILICHOWSKA M,KIMURA N,OUCHI A,et al. Primary hepatic carcinoid and neuroendocrine carcinoma:Clinicopathological and immunohistochemical study of five cases[J].Pathol Int,1999,49(4):318-324.
    [9] DALA R,SHOOSMITH J,LILENBAUM R,et al. Primary hepatic neuroendocrine carcinoma:An underdiagnosed entity[J]. Ann Diagn Pathol,2006,10(1):0-31.
    [10] HSUEH C,TAN XD,GONZALEZ-CRUSSI F. Primary hepatic neuroendocrine carcinoma in a child morphologic,immunocytochemical, and molecular biologic studies[J]. Cancer(Philadelphia),1993,71(8):2660-2665.
    [11] YANG K,CHENG YS,YANG JJ,et al. Primary hepatic neuroendocrine tumor with multiple liver metastases:A case report with review of the literature[J]. World J Gastroenterol,2015,21(10):3132-3138.
    [12] KAYA G,PASCHE C,OSTERHELD MC,et al. Primary neuroendocrine carcinoma of the liver:An autopsy case[J]. Pathology International,2001,51(11):874-878.
    [13] AKAHORI T,SHO M,TANAKA T,et al. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors[J].Anticancer Res,2013,33(8):3355-3358.
    [14] Expert Group of Chinese Consensus on Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Neoplasm. Chinese consensus on pathological diagnosis of gastroenteropancreatic neuroendocrine neoplasm(2013)[J]. Chin J Pathol,2013,42(10):691-694.(in Chinese)中国胃肠胰神经内分泌肿瘤病理诊断共识专家组.中国胃肠胰神经内分泌肿瘤病理诊断共识(2013年版)[J].中华病理学杂志,2013,42(10):691-694.
    [15] DOMNGUEZ N,ESTVEZ-HERRERA J,PARDO MR,et al.The functional role of chromogranins in exocytosis[J]. J Mol Neurosci,2012,48(2):317-322.
    [16] BOSMAN FT,CARNEIRO,HRUBAN RH,et al. WHO classification of tumors of the digestive system[M]. 4th ed,World Health Organization,2010.
    [17] WEISS VL,KIERNAN C,WRIGHT J,et al. Fine-needle aspiration-based grading of pancreatic neuroendocrine neoplasms using Ki-67:Is accurate who grading possible on cytologic material?[J]. J Am Soc Cytopathol,2018,7(3):154-459.
    [18] KNOX CD,ANDERSON CD,LAMPS LW,et al. Long-term survival after resection for primary hepatic carcinoid tumor[J].Ann Surg Oncol,2003,10(10):1171-1175.
    [19] IWAO M,NAKAMUTA M,ENJOJI M,et al. Primary hepatic carcinoid tumor:Case report and review of 53 cases[J]. Med Sci Monit,2001,7(4):746-750.
    [20] DONG X,CARR BI. Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors:A long—term follow-up in 123 patients[J]. Med Oncol,2011,28(Suppl):s286-s290.
    [21] RAJ N,VALENTINO E,CAPANU M,et al. Treatment response and outcomes of grade 3 pancreatic neuroendocrine neoplasms based on morphology:Well differentiated versus poorly differentiated[J]. Pancreas,2017,46(3):296-301.
    [22] PARK CH,CHUNG JW,JANG SJ,et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas[J].J Gastroenterol Hepatol,2012,27(8):1306-1311
    [23] VLADIMIR N,ELECTRON K. Management options for advanced low or intermediate grade gastroenteropancreatic neuroendocrine tumors:Review of recent literature[J]. Int J Surg Oncol,2017,2017:1-14.
  • 加载中
计量
  • 文章访问数:  1031
  • HTML全文浏览量:  15
  • PDF下载量:  235
  • 被引次数: 0
出版历程
  • 出版日期:  2020-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回